FHIR IG analytics| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | ValueSet-2.16.840.1.113762.1.4.1248.353.json |
| FHIR Version | R4 |
| Source | https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1248.353/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.353 |
| Version | 20250312 |
| Status | active |
| Date | 2025-03-12T01:08:28-04:00 |
| Name | BacillusCalmetteGuerinForUrologyCare |
| Title | Bacillus Calmette Guerin for Urology Care |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts of medications of Bacillus Calmette Guerin (BCG) .),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that identify a medication of Bacillus Calmette Guerin (BCG) for intravesical use.),(Exclusion Criteria: No exclusions.) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
No narrative content found in resource
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1248.353",
"meta": {
"versionId": "8",
"lastUpdated": "2025-03-12T01:08:28.000-04:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "American Institutes for Research Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2025-03-12"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2025-03-12"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.353",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1248.353"
}
],
"version": "20250312",
"name": "BacillusCalmetteGuerinForUrologyCare",
"title": "Bacillus Calmette Guerin for Urology Care",
"status": "active",
"date": "2025-03-12T01:08:28-04:00",
"publisher": "American Institutes for Research Steward",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: The purpose of this value set is to represent concepts of medications of Bacillus Calmette Guerin (BCG) .),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that identify a medication of Bacillus Calmette Guerin (BCG) for intravesical use.),(Exclusion Criteria: No exclusions.)",
"compose": {
"include": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept": [
{
"code": "1653484",
"display": "BCG, live, Tice strain 50 MG/ML Topical Suspension"
},
{
"code": "1653579",
"display": "BCG, live, Tice strain 50 MG Injection"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:17a017f9-7091-48ef-9b26-ef4ae6ef8ff8",
"timestamp": "2025-05-23T20:57:52-04:00",
"total": 2,
"contains": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1653484",
"display": "BCG, live, Tice strain 50 MG/ML Topical Suspension"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1653579",
"display": "BCG, live, Tice strain 50 MG Injection"
}
]
}
}